Nepal Journal of Medical Sciences | Original Article line inexpensive antibiotics, chloramphenicol, amoxicillin and co-trimoxazole} S. Typhi and Paratyphi A. 2 High level ciprofloxacin resistance has become common.
Levofloxacin has a broad spectrum of antimicrobial activity, and is effective against gram-positive and gram-negative bacteria. It may be a better choice than ciprofloxacin because of its excellent proven clinical efficacy and lower incidence of adverse gastrointestinal reactions in this kind of infection. 3 Data regarding the efficacy of levofloxacin in the treatment of typhoid fever is at present not available. The purpose of this study was to perform antibiotic susceptibility test and compare the antibiotic susceptibility pattern of different classes of antibiotics with levofloxacin. In addition, the study also determined the levofloxacin susceptibility pattern of MDR isolates
Methods:
The Institute guideline. Antibiotic discs tested were amoxicillin ( 10mg ), ceftriaxone ( 30mg ), chloramphenicol ( 30mg ), ciprofloxacin ( 5mg ), cotrimoxazole ( 25mg ), levofloxacin ( 5mg ) and nalidixic acid ( 30mg ) (Hi Media Laboratory Ltd., Mumbai, India). The zone of inhibition was noted. Statistical analysis was performed using WIN PEPI Software ( version 7.9 ).
Result:
Out of 50 isolates of Salmonella enterica, 31 (62%) were S. Typhi and 19 (38%) were S. Paratyphi A. All the isolates were sensitive to chloramphenicol and ceftriaxone. NAR (94%) was high and one isolate (2%) was resistant to levofloxacin (Table 1) .
Levofloxacin resistant S. Paratyphi A was not observed. Furthermore, antibiotic resistant and MDR S. Typhi (n=6) was higher than S. Paratyphi A (n=4 ) ( Table 2 ).
Ten (20%) isolates were MDR of which, 9 MDR isolates were susceptible to levofloxacin whereas 1 was resistant.
The levofloxacin resistant isolate was MDR S. Typhi. 
Discussion:
All the isolates in our study were susceptible to ceftriaxone and chloramphenicol similar to the previous reports from Nepal. 4 This suggest the possible use of chloramphenicol and third generation cephalosporins in the treatment of enteric fever but the misuse, overuse and self prescription should be discouraged in order to limit the emergence of drug resistance.
In a present study, Nalidixic acid resistance (NAR) was high in both S. Typhi (96.7%) and S. Paratyphi A (89.2%) in comparison to the study from Nepal in 2005 which shows 73.3% and 94.9% NAR S. Typhi and S. Paratyphi A respectively. 5 This indicates the increasing trend of reduced susceptibility to fluoroquinolone antibiotics similar to the reports from different parts of the world with alarming evidence.
In present study, fluoroquinolone resistant S. Paratyphi A was not observed whereas 3 ( 8% ) isolates of S. Typhi were resistant to ciprofloxacin and 1 (3%) was resistant to levofloxacin. Previous study shows 2 ( 5% ) isolates of S. Typhi and 2 ( 9% ) isolates of S. Paratyphi A were resistant to ciprofloxacin. 6 Comparatively higher drug resistance in S. Typhi than S. Paratyphi A in our study was dissimilar to the previous reports which may be due to lower sample number.
Resistant Salmonella and failure of ciprofloxacin therapy have also been reported from studies conducted in central Nepal. 7 This may be due to the recommendation of fluoroquinolones as first line therapy for enteric fever, particularly in children, irrespective of sensitivity patterns and without a thorough analysis and assessment of quality of evidence
The decreasing trend of MDR was observed in our study as in other studies from different parts of the world including Nepal. In the present study, ten (20%) isolates were MDR which is lower in comparison to the report ( 26 % ) from Eastern Nepal in 2004 and MDR S. Typhi (60%) was lower than reported ( 92%) in 2008 from Nepal. 9, 10 Only 1 MDR S. Typhi was observed resistant to levofloxacin by disc diffusion method. Though it shows the significance of the levofloxacin in the treatment of the enteric fever, the NAR strains need higher concentration of fluoroquinolone for the treatment.
Conclusion:
High level of nalidixic acid resistance and even some fluroquinolone resistance shows the treatment of the enteric fever can not be relied on the fluoroquinolones. It has been an important to perform minimum inhibitory concentration test for the complete evaluation of the fluoroquinolones sensitivity to the nalidixic acid resistant isolates.
